MedTrace Logo

Eradication of H-pylori in Pregnancy and Its Effect on Iron Replacement Therapy?

NCT03347513 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2018-12-04

No results posted yet for this study

Summary

the effect of eradication of H-pylori in pregnant patients with iron deficiency anemia on the level of hemoglobin after iron therapy.

Conditions

  • Pregnancy Complications
  • Anemia, Iron Deficiency
  • H Pylori Infection

Interventions

DRUG

triple attack therapy

eradication of H-pylori using triple attack therapy.

DRUG

Ferrous(II)-glycine-sulphate complex 567.7 mg capsules

Iron therapy will be given to both groups twice daily for one month.

Sponsors & Collaborators

  • Kasr El Aini Hospital

    lead OTHER

Principal Investigators

  • Ahmed Kamel, M.D. · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-11-25
Primary Completion
2019-03-31
Completion
2019-05-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03347513 on ClinicalTrials.gov